List view / Grid view
Scaling up cell therapy is no easy feat. PluriCDMO's Andy Lewin reveals the critical factors for success and how they are helping companies bring life-saving therapies to market.
TALEN was shown to be almost five times more efficient than CRISPR-Cas9 at locating and editing genes in heterochromatin.
Researchers announce positive pre-clinical results for two sickle cell disease treatment strategies.
Researchers have for the first time used a gene editing technique to successfully cure a genetic condition in a mouse model...
